HPV vaccine shows promise for girls on Immune-Suppressing drugs

NCT ID NCT01687192

Completed ⭐️ VACCINE ⭐️ Sponsor: University Hospital, Bordeaux Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether the HPV vaccine works in girls aged 9 to 17 who are taking medicines that weaken their immune system, such as after an organ transplant or for diseases like lupus. The goal was to see if their bodies produce enough antibodies to protect against HPV. The results help doctors understand if these girls can get the same protection from the vaccine as healthy girls.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SYSTEMIC IMMUNE DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV Seropositivity immune system disorder systemic lupus erythematosus human papilloma virus infection prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SYSTEMIC IMMUNE DISEASE SYSTEMIC LUPUS ERYTHEMATOSUS TRANSPLANTATION

Contacts and locations

Locations

AP-HP, Hôpital Armand Trousseau

Paris, 75571, France
AP-HP, Hôpital Necker-Enfants

Paris, 75743, France
AP-HP, Hôpital Robert Debré

Paris, 75019, France
CHU de Bordeaux, Hôpital Pellegrin-Enfants

Bordeaux, 33076, France
CHU de Lille, Hôpital Jeanne de Flandres

Lille, 59037, France
CHU de Montpellier, Hôpital Arnaud de Villeneuve

Montpellier, 34295, France
CHU de Nantes, Hôpital Mère-Enfants

Nantes, 44093, France
CHU de Toulouse, Hôpital des Enfants

Toulouse, 31059, France
HCLyon, Hôpital Femme-mère-enfant

Bron, 69677, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.